The US Food and Drug Administration has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing. Published On 22 Jul 202622 Jul 2026 Peptides, a class of compounds increasingly marketed as wellness treatments, have exploded in popularity in recent years, moving from niche bodybuilding and biohacking circles to…
Doctors treating cancer patients nationwide are facing a shortage of essential generic chemotherapy drugs, a situation that many fear could lead to widespread rationing. The shortages stem from manufacturing problems, shipping delays and decisions by some companies to stop producing the medications, according to the Food and Drug Administration. The decades-old medicines are challenging to…
A foul odor permeated the early morning heat as city workers in Tempe, Ariz., unlocked a sewage monitoring shed and opened the tap of a collection jug that had been siphoning from the city’s wastewater over the previous day. They filled a jar, packed it in a blue cooler and hurried to the next shed,…
Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs. Even so, they’re already outlining their visions for the future of obesity drugs. At the American Diabetes Association’s Scientific Sessions in New Orleans last week, drugmakers pitched doctors and investors on the idea of new shots…
Popular medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight and manage diabetes. New research involving more than 110,000 women found that those taking GLP-1 drugs, a category that includes semaglutide-based medications like Ozempic and Wegovy, were significantly less likely to develop breast cancer. The findings…
Popular GLP-1 drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have already transformed the treatment of type 2 diabetes and obesity. Now, new research suggests these medications may also help prevent and treat addiction across a broad range of substances. Researchers at Washington University School of Medicine in St. Louis found that GLP-1 medications were associated…
A corrupt prison watchdog boss who billed herself “the prisoners’ Deliveroo” has been jailed for five years after admitting sending sexual messages to a killer inmate and smuggling drugs. Helen Spree, 63, was the head of the independent monitoring board (IMB) for HMP Liverpool when she engaged in illicit chats with prisoners over a 20-month…
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder. Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life. “My experience of MDMA was that it just cracked my heart wide open,” said…
In the parlance of undercover operatives, a “legend” is the false identity one concocts to infiltrate a criminal network. “Your legend has to come from you, or it won’t work. Your legend has to be part of you, or it won’t work,” explains Don (Steve Coogan), a British customs agent charged with training a group…
Weight management medications, including Wegovy, Zepbound and Foundayo, will be available to eligible Medicare beneficiaries with a $50 copay starting July. Universal Images Group/Getty Images hide caption toggle caption Universal Images Group/Getty Images Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a…
